Identify & Define Your Cell Therapy’s Biomanufacturing Approach for Critical Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
Critical Quality Attributes (CQAs): Know Their Importance & Limitations in Product & Process… April 27, 2021 Biomanufacturing, Quality & Regulatory
“Known Unknowns” Affect Critical Process Parameters & Critical Quality Attributes in the… April 22, 2021 Biomanufacturing, Quality & Regulatory
Building Effective Multi-Year Process Development Programs II: Evolution of Technology Platform Decisions… March 30, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
Building Effective Multi-Year Process Development Programs I: Estimating hMSC Lot Size Ranges for… March 16, 2021 BioEconomy, Biomanufacturing, Bioprocess Tools, Cell Therapy
Know Your Cost of Goods Recap and Managing Lot Size Estimation November 02, 2020 Cell Therapy, MSCs & Characterization
Final Product Containers for Cell Therapies August 21, 2020 Biomanufacturing, Bioprocess Tools, Cell Therapy
MSC KOL Interview Series: Interoperative Bioprinting for Cranomaxillofacial Reconstruction with Ibrahim… August 07, 2020 Bioprinting & Biofabrication, Tissue Engineering
MSCs as Medical Stockpiled Countermeasures: Cellular “First Responders” for COVID-19 and… May 20, 2020 Biomanufacturing, Cell Therapy, COVID-19
